Smoking, fat mass and activation of the tumor necrosis factor-α pathway

International Journal of Obesity

Volumn 27, Issue 12, 2003, Pages 1552-1556

  Fernandez Real, J M ^a,b   Broch, M ^b   Vendrell, J ^b   Ricart, W ^a,b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Cytokines; Endotoxin; Inflammation; Insulin resistance; Obesity

Indexed keywords

GLUCOSE; INSULIN; LEPTIN; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOELECTRIC IMPEDANCE; BODY FAT; BODY MASS; CONTROLLED STUDY; FAT MASS; GLUCOSE BLOOD LEVEL; HUMAN; IMPEDANCE; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; SMOKING;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ANTIGENS, CD; BLOOD GLUCOSE; BODY MASS INDEX; CONFOUNDING FACTORS (EPIDEMIOLOGY); CROSS-SECTIONAL STUDIES; ELECTRIC IMPEDANCE; HUMANS; INSULIN; LEPTIN; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SMOKING;

EID: 0347511006     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802472     Document Type: Article

References (31)

1. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
2. Willet WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH. Relative and absolute excess risk of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303-1307.
3. Hajjar DP, Pomeranz KB. Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. FASEB J 1992; 6: 2933-2941.
4. Toomey D, Redmond P, Bouchier-Hayes D. Mechanisms mediating cancer cachexia. Cancer 1995; 76: 2418-2426.
5. Tracey KJ, Cerami A. Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med 1992; 200: 233-239.
6. Albanes D, Jones DY, Micozzi MS, Mattson ME. Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 1987; 77: 439-444.
7. Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defences. Clin Sci 1995; 88: 485-489.
8. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996; 9: 1989-1994.
9. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, Feingold KR. Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. A role for leptin in the anorexia of infection. J Clin Invest 1996; 97: 2152-2157.
10. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest 1997; 100: 2777-2782.
11. Qian H, Hausman GJ, Compton MM, Azain MJ, Hartzell DL, Baile CA. Leptin regulation of peroxisome proliferator-activated receptor-gamma, tumor necrosis factor, and uncoupling protein-2 expression in adipose tissues. Biochem Biophys Res Commun 1998; 246: 660-667.
12. Zumbach MS, Boehme MW, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997; 82: 4080-4082.
13. Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 1997; 82: 3408-3413.
14. Hodge AM, Westerman RA, de Courten MP, Collier GR, Zimmet PZ, Alberti KG. Is leptin sensitivity the link between smoking cessation and weight gain. Int J Obes Rel Metab Dis 1997; 21: 50-53.
15. Wei M, Stern MP, Haffner SM. Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol 1997; 7: 81-86.
16. Yoshinari M, Wakisaka M, Fujishima M. Serum leptin levels in smokers with type 2 diabetes. Diabetes Care 1998; 21: 516-517.
17. Niklas BJ, Tomoyasu N, Muir J, Goldberg AP. Effects of cigarette smoking and its cessation on body weight and plasma leptin levels. Metabolism 1999; 48: 804-808.
18. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323-329.
19. Aderka D, Sorkine P, Abu-Abid S, Lev D, Setton A, Cope AP, Wallach D, Klausner J. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest 1998; 101: 650-659.
20. Schroder J, Stuber F, Gallati H, Schade FU, Kremer B. Pattern of soluble TNF receptors I and II in sepsis. Infection 1995; 23: 143-148.
21. Aderka D, Engelmann H, Shemer-Avni Y, Hornik V, Galil A, Sarov B, Wallach D. Variation in serum levels of the soluble TNF receptors among healthy individuals. Lymphokine Cytokine Res 1992; 11: 157-159.
22. Hotamisligil GS, Arner P, Atkinson RL, Spiegelman BM. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 1997; 46: 451-455.
23. Fernández-Real JM, Broch M, Ricart W, Gutiérrez C, Casamitjana R, Vendrell J, Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998; 47: 1757-1762.
24. Hauner H, Bender M, Haastert B, Hube F. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord 1998; 22: 1239-1243.
25. Corica F, Allegra A, Corsonello A, Buemi M, Calapai G, Ruello A, Nicita Mauro V, Ceruso D. Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects. Int J Obes Rel Metab Dis 1999; 23: 355-360.
26. Haack M, Hinze-Selch D, Fenzel T, Kraus T, Kuhn M, Schuld A, Pollmacher T. Plasma levels of cytokines and soluble cytokine receptors in psychiatric patients upon admission: effects of confounding factors and diagnosis. J Psychiatr Res 1999; 33: 407-418.
27. Boström L, Linder LE, Bergström J. Smoking and crevicular fluid levels of IL-6 and TNF-α in periodontal disease. J Clin Periodontol 1999; 26: 352-357.
28. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999; 115: 829-835.
29. Michel OJ, Kips J, Duchateau J, Vertongen F, Robert L, Collet H, Pauwels R, Sergysels R. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641-1646.
30. Spinas GA, Keller U, Brockhaus M. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J Clin Invest 1992; 90: 533-536.
31. Fahmi H, Chaby R. Selective refractoriness of macrophages to endotoxin-induced production of tumor necrosis factor, elicited by an autocrine mechanism. J Leukoc Biol 1993; 53: 45-52.